Verifying…
Home / Drug A–Z / Lirimotil Tablet 2 mg_

Lirimotil Tablet 2 mg_

NAFDAC Reg. No. A4-101497 · Drug

Registered with NAFDAC — registration activeAs of 5 November 2026 · synced automatically from official sources.
Product
Lirimotil Tablet 2 mg_
NAFDAC number
A4-101497
Active ingredient
Loperamide Hydrochloride
Strength
2 mg
Form
Tablet
Pack size
1 x 10's (in Alu-PVC blister)
Manufacturer
Not listed
Applicant (holder)
Liricon Pharmaceutical Limited
Approved
27 Aug 2025
Status
Active View on NAFDAC ↗
Registration valid to
26 Aug 2030
WHO alerts
None found
Community reports
None
Times checked
0

RxVerify commentary

  • Lirimotil Tablet 2 mg_ is on the NAFDAC register with an active registration (A4-101497). A valid number alone does not prove a pack is genuine — counterfeiters copy real numbers, so also check the expiry date, seal and print quality.

Generated automatically from the NAFDAC register, WHO alerts and community data as of today. Not medical advice — always follow your doctor or pharmacist.

What Lirimotil Tablet 2 mg_ is used for

From the official U.S. FDA label for loperamide hydrochloride, the active ingredient registered with NAFDAC.

What it is used for

controls symptoms of diarrhea, including Travelers’ Diarrhea

Purpose

Anti-diarrheal

Possible side effects

• symptoms get worse • diarrhea lasts for more than 2 days • you get abdominal swelling or bulging. These may be signs of a serious condition.

Do not use if

if you have bloody or black stool

Warnings

Allergy alert: Do not use if you have ever had a rash or other allergic reaction to loperamide HCl Heart alert: Taking more than directed can cause serious heart problems or death Do not use if you have bloody or black stool Ask a doctor before use if you have • fever • mucus in the stool • a history of liver disease • a history of abnormal heart rhythm Ask a doctor or pharmacist before use if you are taking a prescription drug. Loperamide may interact with certain prescription drugs. When using this product tiredness, drowsiness or dizziness may occur. Be careful when driving or operating machinery. …

Pregnancy & breastfeeding

If pregnant or breast-feeding, ask a health professional before use.

Storage

• each 30 mL contains: sodium 15 mg • store between 20-25 ° C (68-77 ° F)

General information only — not dosing advice. Always follow the leaflet in your pack and your doctor or pharmacist.

Check your pack of Lirimotil Tablet 2 mg_

Add the expiry date printed on your pack for a full Trust Score — or look up uses, side effects and cheaper generics.

3 free checks left today · no signup Official sources: NAFDAC Green Book & recalls · WHO · U.S. FDA · NLM RxNorm

About Lirimotil Tablet 2 mg_

What is in Lirimotil Tablet 2 mg_?

Lirimotil Tablet 2 mg_ contains Loperamide Hydrochloride (2 mg), as tablet, according to its NAFDAC registration record.

Is Lirimotil Tablet 2 mg_ registered with NAFDAC?

Yes. Lirimotil Tablet 2 mg_ is listed on the NAFDAC register under registration number A4-101497, and its registration is active as of 5 November 2026.

Has Lirimotil Tablet 2 mg_ been flagged as fake or recalled?

No WHO falsified or substandard medical product alert currently matches Lirimotil Tablet 2 mg_ in our automatically synced alert list.

How can I check that my pack of Lirimotil Tablet 2 mg_ is genuine?

Run a free authenticity scan with the NAFDAC number A4-101497, your pack's expiry date and batch number to get a Trust Score, compare the pack with the NAFDAC record (ingredient, strength, form, manufacturer), and buy only from licensed pharmacies.

What is Lirimotil Tablet 2 mg_ used for?

controls symptoms of diarrhea, including Travelers’ Diarrhea (Summarised from the official U.S. FDA label for loperamide hydrochloride. Always follow your doctor or pharmacist.)

Patient reviews

–No reviews yet
5★
0
4★
0
3★
0
2★
0
1★
0
Have you used Lirimotil Tablet 2 mg_? Share your experience to help other patients. Sign in to review

Reviews are personal experiences from RxVerify users, not medical advice. Report side effects to your doctor and to NAFDAC.